The Dogs Trust has officially launched the Free Microchipping Through Vets Campaign through which all owners can get their dog microchipped free of charge through participating veterinary practices.
Microchipping becomes compulsory for all dogs in England in April 2016 and Wales in March 2015, and with 20% of dogs in the UK still unchipped, the charity says it thinks demand for the procedure is likely to be significant over the coming year.
1500 practices have already joined the year-long campaign, as part of which they will be given free microchips in exchange for implanting them at no cost to the owner. The charity says it hopes that up to 75% of the UK's 3075 practices will have joined the campaign within the next few weeks.
Clarissa Baldwin, Chief Executive of Dogs Trust, said: "We are delighted about the proposed new legislation and see it as the start of a very positive movement. From April 2016 in England and March 2015 in Wales it will be compulsory for each and every dog to be microchipped on first change of hands which represents a significant step forward for dog welfare and responsible dog ownership. To show its support for the implementation of this legislation, Dogs Trust is teaming up with vets to make sure that all dog owners can have the procedure done for free. We'd like to say a huge thank you to the vet practices already supporting the campaign and urge others to come on board. An essential element to the success of microchipping is for dog owners to take responsibility for updating their details with the database should their circumstances change.
"Last year 111,986 stray and abandoned dogs were picked up by Local Authorities across the UK, with only 40% reunited with their owners. This initiative will help to reduce that number dramatically."
To join the campaign vet practices should contact Dogs Trust at campaigns@dogstrust.org.uk
The 2014 Vet Charity Challenge is now open and teams can register via the website at www.vetcharitychallenge.co.uk.
The event takes place on Saturday 27th September at St Francis School, Pewsey, near Marlborough in Wiltshire. The day consists of teams of four taking part in walking/running, cycling and kayaking, some orienteering as well as some mental and physical tasks. All the time trying to gain as many points as possible. Last year the event raised over £50,000 for the three selected animal based charities. In 2014 the charities being supported are Hearing Dogs for Deaf People, SPANA and Cats Protection.
Gavin Mitchell from BCF Technology said: "Interest in the Vet Charity Challenge was so great last year that we had teams on a waiting list. To ensure your team gets a place we highly recommend that you register your team on the website early. We will be entering five teams from BCF this year, such is the demand from our own staff."
Andrew Groom from Kruuse added: "The Vet Charity Challenge is a great event. Helping you build your team within your veterinary practice, acting as a goal for those that want to become a bit fitter, encouraging training together over the summer months. It is great fun and also raises considerable sums of money for some really deserving charities. Don't delay, get your teams together and register now on the website. The event is designed for all levels of fitness. It is not the fittest team that wins, but the team that works the best together."
Novartis Animal Health has announced the launch of Strenzen, an oral water medication for pigs, indicated for the treatment of gastrointestinal infections caused by Escherichia coli, Clostridium perfringens and Salmonella Typhimurium, and for respiratory tract infections caused by Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.
Strenzen contains contains a combination of amoxicillin trihydrate (500 mg/g) and potassium clavulanate (125 mg/g) in ratio of 4:1. Novartis says it is ideally suited for the treatment of post-weaning infections in pigs.
According to the company, the combination of amoxicillin and clavulanic acid broadens the performance of amoxicillin1,2, especially against resistant strains of bacteria capable of producing ß-lactamase enzymes. Certain bacteria are able to produce ß-lactamase enzymes as a protection mechanism, making the amoxicillin molecule ineffective against them. The clavulanic acid in Strenzen binds to the molecules of the ß-lactamase enzyme, ensuring the amoxicillin remains unaffected and free to attack bacteria. Prof. Dominiek Maes, DVM, MSc, MS, PhD, Dipl. ECVPH, Dipl. ECPHM, from the Porcine Health Management Unit of the Ghent University, Belgium said: "Weaning is a stressful event for piglets and there are several opportunistic diseases that can impact them during this period. The challenge with E. coli and S. suis infections is that in many countries there are currently no commercial vaccines available with proper efficacy. I believe Strenzen can indeed be very helpful in managing those infections which are so prevalent after weaning."
Novartis says Strenzen is rapidly excreted, leading to a withdrawal period of one day, which in turn maximizes production flexibility for pig producers. In addition, the water-soluble formulation of Strenzen ensures that treated pigs get a therapeutic dose even when they stop eating, making it an ideal treatment for sick pigs with compromised appetites.
Recent field trials on infected farms in Spain and the Czech Republic demonstrated that Strenzen-treated pigs give better production performance, better economic returns and require less medical intervention3,4,5. The reduction of the overall amount of antibiotics needed to treat severe post-weaning infections not only saves producers the costs of the labour and the medication, but is also important in regard to the development of resistance in bacteria.
Dr. Ulrich Klein, Global Technical Services Manager, Novartis Animal Health said: "With the launch of Strenzen, Novartis Animal Health demonstrates its commitment to continually broadening our product portfolio to address the specific needs of farmers and food producers. Strenzen has the ideal spectrum for the treatment of post-weaning infections, delivering better productivity results than current therapies for those infections."
References
The RCVS is calling on veterinary surgeons and students, and listed or registered veterinary nurses to complete its Survey of the Professions 2014.
The four-yearly, confidential survey provides the College with data that helps it develop policy, plan its activities and respond to questions from stakeholders such as government and the media.
The survey aims to find out more about individuals' employment type and experiences, working patterns and professional development. It also asks about aspirations for the short- and long-term and current views on the veterinary profession.
Questions are also asked about mental health and well-being, using the Warwick-Edinburgh Mental Well-Being Scale. The data will be used to track the mental well-being of the profession at a population level over successive years - a process that started with the 2010 survey - which will feed into other work being carried out across the profession.
Finally, the survey includes a set of questions about 24/7 emergency cover, the answers to which will feed into the RCVS Standards Committee's current evidence-gathering exercise.
This year the survey, which is being carried out by the Institute for Employment Studies, will only be available online. All those for whom the RCVS has a personal email address (ie not 'info@' or similar) have been sent a participation request. Others will be sent a letter, including the survey URL. Those who do not receive this letter by Monday 14 April should contact Lizzie Lockett, on l.lockett@rcvs.org.uk or 020 7202 0725.
The deadline for completion of the survey is 30 April.
Canterbury-based solicitor Cooper & Co, which specialises in dog law, has launched a series of CPD-qualifying webinars for veterinary professionals available at www.doglaw.tv.
The webinars, which are presented by Trevor Cooper, cover a wide variety of subjects, including:
In addition, the site hosts videos about dog behaviour by the well-known dog trainer and behaviourist Carolyn Menteith. The topics covered in her videos include:
Whilst the videos are CPD-qualifying for veterinary professionals, they are also aimed at anyone else that works with dogs, and dog owners themselves.
To view the videos visit www.doglaw.tv.
A new study from the University of Surrey, published today in the journal PLOS One, has identified the specific effects of a malformation which affects affects toy breeds.
According to researchers, Chiari malformation has become prevalent as a result of selective breeding and affects many toy dog breeds which have been bred to look more doll-like, including Griffon Bruxellois, Cavalier King Charles Spaniels, Chihuahuas and their crosses.
Researchers took brain, skull and vertebrae measurements of 155 Griffon Bruxellois and compared dogs affected by the condition with normal Griffons. They discovered that Griffons with the disease had taller foreheads and that it had also caused the shape of the brain to change, with severely affected animals having their cerebellum pushed underneath the main part of the brain.
The researchers say that although it can be asymptomatic, in many dogs Chiari malformation can cause headaches, problems with walking or even paralysis.
The condition can also affect humans and the University is working with human geneticists at the University of Montreal, in the hope that better understanding of the condition will lead to improved treatment for both dogs and humans.
Lead author, Dr Clare Rusbridge from the new School of Veterinary Medicine at the University of Surrey, said: "Chiari malformation can be described as trying to fit a big foot into a small shoe. It can be very painful, causing headaches and pressure on the brain and can result in fluid filled cavities in the spinal cord. Our latest discoveries will be significant in driving this research forward and hopefully allow us to identify which genes may be associated with the condition.
"Our next steps will be to apply our technique to other breeds with Chiari malformation and investigate more sophisticated ways of screening, so that risk of disease can be detected more easily, at an earlier age and with a single MRI scan.
"We want to engage breeders and give them practical advice about the condition, but it is also important that the public recognises that breeding dogs in a certain way to influence how they look might not be in the animal's best interest. There are responsible breeders out there, who have invested in screening and who are breeding for health as well as producing attractive puppies, and it is vital that people only look to buy from them."
Novartis Animal Health has launched Farming against BVD, a new initiative to help in the fight against Bovine Viral Diarrhoea (BVD).
The campaign, which is being carried out in partnership with key industry bodies, will begin with an independent survey of farmers, the results of which will be announced in April.
An expert panel, headed by Professor Joe Brownlie (Royal Veterinary College and Chairman of the BVD Scientific and technical working group), will then come together to analyse the findings, using them to shape and drive an industry response.
Professor Brownlie said: "BVD is a costly and complex disease, spread by a pestivirus that affects the reproductive and immune systems. Persistently Infected (PI) animals are the main source of infection, but can be hard to identify without testing. Only total eradication will prevent the disease from spreading. Eradication Schemes in a number of European countries have already succeeded and Scotland and Ireland have embarked on similar schemes. The information being gathered will help the industry to develop a much needed scheme for England and Wales."
Joining Professor Joe Brownlie on the expert panel will be Dr Peter Nettleton (Moredun Research Institute), Mansel Raymond (dairy farmer and Chairman of the NFU Dairy Board), Caroline Dawson (Novartis Animal Health veterinary surgeon) and Paddy Gordon (veterinary practitioner).
Survey topics will include levels, and methods, of testing for BVD on farm, understanding of the role of PI animals and the financial impact of BVD on dairy and beef units. Farmers will also be asked who they look to for advice and how they view the role of vaccination.
Caroline Dawson MRCVS from Novartis Animal Health said: "Countrywide eradication may not be achieved for a number of years, although individual farmers can control the disease on their own farms within 1-2 years, providing substantial cost benefits. The purpose of this campaign is to encourage farmers to take action now against BVD. By working closely with their vets, identifying and removing PI animals, BVD can be removed. Ensuring adequate biosecurity and a robust vaccination policy will eliminate the risk of bringing BVD back onto the farm."
Professor Brownlie said: "Understanding what farmers understand about BVD, particularly the role of the PI animal, will enable members of the panel and the wider industry, including Novartis and the BVD Stakeholder Group, to meet farmer needs more accurately. Greater awareness of the problem is vital - this is the only way that progress towards eradication will be made."
Horses suffering from neurological conditions similar to those that affect humans could be helped by a breakthrough from stem cell scientists, according to a study published in the journal Stem Cells and Development.
Researchers at the University of Edinburgh's Roslin Institute took skin cells from a young horse and turned them into stem cells using a technique that was originally developed for human cells. The reprogrammed cells are pluripotent, which means they can be induced to become any type of cell in the body. The team used them to create nerve cells in the laboratory and tested whether they were functional by showing that they could transmit nerve signals in a test tube.
The university says horse stem cells have been produced in the laboratory before but this is the first time that scientists have created working cells of a specific type from them. The advance may pave the way for cell therapies that target conditions similar to motor neurone disease.
In addition, the research could also benefit horses affected by grass sickness, a neurological condition that affects around 600 horses a year in the UK. Little is known about the disease, which causes nerve damage throughout the body. It is untreatable and animals with the most severe form usually die or have to be put down.
Dr Xavier Donadeu from the Roslin Institute, an author of the study, said: "Stem cells hold huge therapeutic potential both for people and animals. Our research is an important step towards realising that potential for horses and provides an opportunity to validate stem-cell based therapies before clinical studies in humans."
The British Association of Veterinary Emergency and Critical Care (BAVECC) is carrying out a survey of the veterinary profession about 24/7 emergency veterinary cover, the results of which will be presented to the RCVS Standards Committee during its forthcoming review.
Toby Birch MRCVS from BAVECC said: "We are aware that there has been much debate on the subject however we feel that much of what has been aired is subjective opinion. While we appreciate that this is very valuable, BAVECC would like to try and place some objectivity on this matter."
If you're working in small animal practice in the UK, please take part in the survey here: https://www.surveymonkey.com/s/JYKNC5J.
The results will be shared with members of VetSurgeon.org and VetNurse.co.uk in due course.
The Pet Food Manufacturers Association (PFMA) has published the results of research which found that veterinary surgeons believe 45% of all pets are overweight.
In addition, 77% of the 180 vets surveyed at the London Vet Show 2013 believe that the pet obesity problem is on the rise.
Meanwhile, 93% of pet owners said they would be concerned to discover their pet is overweight, revealing a sharp divide between vets' and owners' perceptions.
To help spread the word about ideal pet weight, the PFMA will launch a new campaign called #GetPetsFit on 7th May.
Michael Bellingham, Chief Executive of PFMA said: "We need to engage pet owners emotionally, helping them realise that feeding and exercising their pet to the optimum level can result in an extra two years of active life. The #GetPetsFit campaign will provide the perfect opportunity to do this and we hope that with the help of vets, we can work to resolve this important issue."
The PFMA is urging practices to promote good nutrition and a healthy lifestyle. Zara Boland BVSc BE MRCVS, Founder of Vet Voice Ltd says: "It is encouraging that success rates are high for the 78% of UK vets already running companion animal obesity clinics. However, we must continue pushing the health message until overweight pets are no longer seen as the 'norm'. We need widespread recognition of pet obesity to pave the way for positive action."
One way that the PFMA is encouraging practices to get involved is by running Weigh in Wednesdays from 7th May. To help, the organisation has prepared a free kit that contains campaign posters, website banners and client hand-out materials, including Pet Size-O-Meters (for cats, dogs, rabbits and birds), a pet food diary and weight and body condition log. You can either download the kit here: www.pfma.org.uk/weighinwednesday or visit PFMA's homepage and ask for a free pack to be sent to your practice.
The BVA has paid tribute to Lord Ballyedmond, founder of the veterinary pharmaceutical company Norbrook Laboratories, after he was killed in a helicopter crash in Norfolk last Thursday.
The life peer (pictured second from left collecting a business award in 2011) founded Norbrook over 40 years ago. It became one of the biggest manufacturers of animal health products globally, and now employs more than 1000 people. Dr. Edward Haughey, as he was previously known, was ennobled in 2004.
Following his death, Norbrook issued the following statement:
"It is with sincere sadness and deep regret that the Company confirms our founding Chairman and CEO, Lord Ballyedmond, was one of four people who tragically lost their lives in an aviation accident at Gillingham, Norfolk at approximately 7.30pm on Thursday 13 March 2014.
Norbrook management and staff also mourn the loss of their friends and colleagues Declan Small (Site Foreman), Captain Carl Dickerson (Pilot) and Captain Lee Hoyle (Pilot).
Our thoughts are with the immediate families and friends of the deceased who have requested privacy at this difficult time.
We take enormous pride in our Chairman's extraordinary legacy in establishing Norbrook as a global veterinary and pharmaceutical industry leader. Management will continue to advance his pioneering vision with a renewed vigor and determination befitting his memory."
BVA President Robin Hargreaves said: "We are deeply saddened to hear of the tragic passing of Lord Ballyedmond. He has been a great supporter of the veterinary profession and of BVA, and made an enormous contribution to veterinary medicine. He built opportunity for thousands of people in Northern Ireland and around the world and had a huge commercial and industrial presence throughout my whole career. Above all Lord Ballyedmond was a family man and all our thoughts are with his wife and children at this time."
Merial has announced the launch of V LINE, a new range of parasiticides sold exclusively through veterinary practices.
The first two products, called Broadline for cats and NexGard for dogs, will be unveiled at the BSAVA Congress at the start of next month.
Broadline is a broad-acting POM spot-on for cats containing eprinomectin, praziquantel, s-methoprene and fipronil, indicated for use against tapeworms, ticks, roundworms and fleas.
NexGard is a POM flea and tick control product for dogs given monthly as a palatable soft chew. It contains a novel active ingredient called afoxolaner which, according to Merial, has a new and distinct mode of action that provides a fast speed of flea kill.
Roddy Webster, Head of Pets at Merial said: "We are pleased to announce the launch of Broadline and NexGard. Merial is a market leader with a strong heritage in anti-parasitics and we have leveraged that expertise as well as our understanding of what pet owners want, to deliver these truly consumer-focused solutions. Such prescription-only innovations also demonstrate our ongoing commitment to the veterinary profession."
Elanco Animal Health has announced that there have been extensions to the withdrawal periods for Dectomax (doramectin) 10 mg/ml Solution for Injection and Micotil (tilmicosin) 300 mg/ml Solution for Injection.
For Dectomax injectable, meat withdrawal for cattle and sheep will be extended to 70 days and pigs to 77 days. For Micotil, sheep milk withdrawal will be extended to 18 days and milk from cows during the dry period or from pregnant heifers should not be used for human consumption until 36 days after calving.
Elanco is reminding veterinary surgeons and SQPs that they may continue to prescribe according to the current label but it is good practice to implement revised withdrawal periods. The company is also taking this opportunity to highlight the importance of getting into the habit of double-checking withdrawal periods when administering drugs, because they do change from time to time in the light of new knowledge.
Axiom Veterinary Laboratories is launching MiLab, a new range of in-practice analysers at the BSAVA Congress.
Axiom says the range will be supported with a comprehensive range of additional services, from installation and training through to technical support and maintenance.
Martyn Carpenter, Managing Director of Axiom Veterinary Laboratories said: "An increasing number of UK veterinary practices are opting to carry out a higher proportion of laboratory testing in-house but, in order to do this successfully, they need equipment which is reliable, cost-effective and easy-to-use. Two products in the MiLab range will be showcased at BSAVA, both of which have been selected following extensive validation and correlation testing in Axiom's veterinary laboratories."
The two new products are:
Martyn said: "Investing in significant new equipment is always challenging for practices and we have spoken to many over the last 18 months to understand their experience of and current requirements for in-house analysis and, in particular, the level of support they receive. Practices working with us can be confident that we are offering the very latest in analyser technology, which has been tested rigorously for reliability, economy and ease of use. They can also feel secure in the knowledge that we provide a high level of service and support, delivered by our own highly skilled laboratory technicians."
For more information, contact Steve Clarke at Axiom on 01626 357756.
The RCVS has announced that 19 people are standing in this year's RCVS Council elections, including, for the first time, more women than men, and a much lower average candidate age.
Of the 19 candidates - believed to be the highest number since records began - ten are women. Not only is this the most women ever to stand, but it is in direct contrast to last year where all 13 candidates were men. Additionally, whereas the average age of all elected Council members in March 2013 was 56.5 (57 for women and 56 for men), the average age of this year's candidates is 47 (45 for women and 48 for men).
The RCVS Council candidates are:
Last year, the all-male candidate list prompted concern from the profession and calls for the College to investigate the reasons behind the lack of women and to take steps to redress the balance. The then RCVS President Jacqui Molyneux invited feedback from the profession about the barriers to joining Council, and set up a working party, chaired by Council member Amanda Boag, to look at how participation could be widened, not only to women, but also younger members of the profession and those actively engaged in clinical practice.
The working party suggested a number of initiatives, including a mentoring scheme, providing more practical information about being a Council member (see www.youtube.com/rcvsvideos), and inviting prospective candidates to the RCVS to discuss the role in more detail.
Amanda said: "The College's efforts to broaden participation in its election process seem to have paid dividends. I'm delighted there is so much more diversity amongst the election candidates this year, and that so many women have decided to throw their hat into the ring, especially as women now form over 50% of the profession. I'm very much looking forward to the outcome of the elections, and hope that this dramatic increase in candidates in turn prompts an excellent turnout."
In a slightly later start to the voting period this year, ballot papers and candidate details will be posted on 19 March 2014, and all votes must be cast, either online or by post, by 5pm on Friday, 25 April 2014.
In the meantime, the College is inviting all voters to think about the one question they would like to put to the candidates and submit it in time for this year's 'Quiz the Candidates', to be broadcast by the Webinar Vet on the evening of 20 March. All questions received will be put to the candidates, who will each then answer two questions of their choice, as well as explaining what they consider sets them apart as a potential Council member. The candidates' answers will be pre-recorded (due to the large number of candidates) and made available online at around 8:00pm on 20th March.
Questions (one per person) for RCVS Council should be submitted to the RCVS by 12 March via its dedicated election websites, available soon at www.votebyinternet.com/vetvote14, on twitter using the hashtag #vetvote14, or by email to vetvote14@rcvs.org.uk.
Bayer Animal Health has launched a new initiative designed primarily to help veterinary students and bridge gaps in their knowledge about the use of veterinary antibiotics.
The initiative kicks off with two surveys, one for qualified veterinary surgeons here, and one for veterinary students here. The objective of the surveys is to gain an insight into the use and understanding of antibiotics both in practice and in training. They also aim to discover the influences and concerns involved when veterinary surgeons select a course of antibiotics.
The results of the survey will be shared with the profession and used to develop a new educational resource which will be shaped by the results of the survey and available to students in their clinical years. Bayer says it hopes the new resource may also be beneficial for vets in practice who have concerns about the use of antibiotics.
If that isn't reason enough to take part in the survey, all participants will be entered into a draw for an iPad mini.
Vicky McAlister, Group Product Manager at Bayer said: "The importance of understanding the concerns of vets and vet students in responsibly prescribing antibiotics is essential when looking at the issue of antibiotic resistance and the implications for the future of animal health. The large number of antibiotics available can present a challenge and lead to confusion when prescribing. The surveys provide a unique opportunity for vets and students to shape learning and reference resources that address the specific challenges they face when choosing and using antibiotics".
The surveys close on 24th March 2014.
The RCVS is reminding veterinary surgeons that their renewal fees to remain on the Register for 2014/15 are now due.
Registration renewal forms have been sent to all vets reminding them that payment to remain on the Register is due by 31 March 2014. If the College does not receive payment before 1 April, £35 will be added to the renewal fee and any vets who have still not paid before 1 June will be removed from the Register.
This year the RCVS has updated its online 'My Account' area (www.rcvs.org.uk/login) to allow vets to manage their details and pay their renewal fees more quickly and easily. Login details have been sent to all vets and the system is now operational. The changes to the area are the first phase of a project to make it more accessible and user-friendly and to allow vets to better manage their details online.
As part of the renewal process, vets are asked to confirm that their details on the Register are correct, including membership category and correspondence details. Those who are in the 'UK Practising' or 'Practising outside the UK' membership categories should also confirm - via the registration renewal form or the online 'My Account' area - that they are compliant with the requirements for continuing professional development (CPD) of 105 hours over three years. Vets with any cautions, convictions or adverse findings against them dating from 1 January 2006 onwards, should also declare them. For further details on these declarations vets should visit www.rcvs.org.uk/convictions.
Fees can be paid by credit card through the 'My Account' area or by cheque, bank draft or credit card via the registration renewal form sent in the post. Details of how to pay by bank transfer are also on the form.
Vets who have any concerns or questions about renewing their registration, logging in to 'My Account' or who need to request a registration renewal form, can contact the Registration Department on 020 7202 0707 or email membership@rcvs.org.uk.
The Bella Moss Foundation and the Royal Society of Medicine have announced 'One Health', a conference which will bring together experts from the veterinary and medical sectors to collaborate on infectious disease.
Subjects under discussion will include infection control, antimicrobial resistance and the threats posed by emerging zoonotic diseases. Amongst the speakers will be Professor Peter Borriello, Chief Executive of the Veterinary Medicines Directorate and Professor Anthony Kessel, Director of Public Health England. The audience will include policy makers and clinicians together with researchers and academics from both human and veterinary medicine.
Jill Moss, President of the Bella Moss Foundation, said: "With antimicrobial resistance and updated protocols hitting the headlines regularly, our speakers will discuss the key issues. For instance, what exactly is the current status of antimicrobial resistance? How is it affecting our lives? What are the veterinary, medical and research professions doing to resolve the challenges we face - and how can they persuade policy makers to take a united stand on the issue?"
Tom Keith - Welsh president of comparative medicine network, Royal Society of Medicine, said: "Antimicrobial resistance is a global issue requiring education, information and action. The conference programme will provide anyone with an interest in antimicrobial resistance a current and rounded perspective on this important and pressing issue."
For more information, visit: www.onehealthbmf.com.
Dechra Veterinary Products has launched Buprenodale, an opioid analgesic for cats, dogs and horses presented in a 10ml multi-dose vial.
Carol Morgan, Brand Manager said: "Following on from the introduction of Comfortan and Anesketin, our Buprenodale Multidose, 0.3 mg/ml solution for injection for dogs, cats and horses, is the latest addition to the portfolio.
"The active substance in Buprenodale is buprenorphine, the most commonly used opioid analgesic in small animal practice in the UK.
"Buprenodale Multidose joins a portfolio of Dechra products covering a wide range of species, different levels of analgesic efficacy and duration of action.
"The product is now available in a 10 ml multidose vial. It is suitable for post-operative analgesia in dogs and cats; post operative analgesia, in combination with sedation, in horses and potentiation of the sedative effects of centrally acting agents in the dog and horse."
For more information www.dechra.co.uk .
Pulborough-based Arun Veterinary Group has been awarded the title of Best UK Vets, having achieved the largest number of positive online reviews on www.vethelpdirect.com.
The awards are based on the number of positive reviews (4 stars and above) left by owners on the site over the course of the year, with owners asked to review the practice on five key areas: respect for my animal, professionalism, friendliness, cleanliness and value for money.
Comments attached to the 182 reviews for Arun included: "Nothing is too much trouble", "Fabulous vets" and "More like good friends."
Vet Help Direct said: "A good online reputation is so valuable to both local people looking for a service and to business owners. That's why online vet reviews are at the heart of our vet directories. Vet Help Direct is determined to provide a fair reflection of the vet practices in their online directories; all reviews are subject to rigorous tests of authenticity, all are checked for duplicate IP addresses, email addresses and some reviewers are asked to provide evidence that they are recent clients of the practice."
In second place was St Georges Veterinary Group, Wolverhampton, which is now up to 132 reviews and in third place was Goddard Veterinary Group, Gidea Park in London, with 122 reviews.
Ceva Animal Health has added a new CPD module to its Cardio Academy website which focuses on common heart diseases in cats.
The 20 minute online seminar is hosted by Virginia Luis-Fuentes, Professor of Veterinary Cardiology at the Royal Veterinary College. After viewing the module, you can claim a CPD certificate by answering questions relating to the session.
Fraser Broadfoot MRCVS, product manager at Ceva, said: "Cardio Academy is going from strength to strength with over 1500 UK vets registered to the site which now includes 15 hours of free on-demand cardiology CPD with leading specialists."
For more information, visit: www.cardioacademy.cevalearn.com.
Elanco Companion Animal Health has launched a new ordering process for Recuvyra, its transdermal fentanyl solution for the control of postoperative pain relief in dogs.
The new process will enable veterinary practices to purchase Recuvyra, which is a Schedule Two Controlled Drug, without having to complete the online training programme which was has been mandatory since the launch of the product in April 2013.
The company says that training is still highly recommended for every veterinary professional that handles Recuvyra due to its new delivery system. This can be via the short online training course available at www.recuvyratraining.eu or by reading the training leaflet provided with every vial of Recuvyra. The training leaflet includes information on instructions for use, correct administration of the product and special precautions. In addition, client leaflets and other support materials will continue to be available to vets via the website.
Alice Laurens, Recuvyra product manager at Elanco Companion Animal Health, said: "Veterinary practices will still need to follow their wholesalers' procedures for ordering Schedule Two Controlled Drugs when purchasing Recuvyra, however any vet from the practice can now order and sign for delivery of the product making it easier to purchase."
For further information about Recuvyra or Elanco's surgery and pain management range, contact your Elanco Companion Animal Health key account manager or email elancocah.uk@elanco.com.
The RCVS has announced the results of the RCVS Council and VN Council elections.
Re-elected to three of the six seats available on RCVS Council were current President Neil Smith (1,687 votes), incoming Standards Committee Chairman David Catlow (1,656) and Vice-President Jacqui Molyneux (1,304); and, from RCVS Day on 11 July 2014, they will be joined by new members David Bartram (1,674), Susan Paterson (1,496) and Mandisa Greene (1,296).
The two available places on VN Council were taken by existing member Hilary Orpet (611 votes) and new member Amber Richards (371).
Notably, half of the successful RCVS Council candidates this year were women, two of whom being elected for the first time.
Overall turnouts in both elections fell, with 4,137 (16.1%) veterinary surgeons and 1,157 (10%) veterinary nurses voting. These turnouts and voter numbers compare with 4,661 (18.8%) and 1,329 (12.5%) last year, and ten-year averages of 3,927 (17.4%) and 869 (9.9%), respectively.
RCVS Registrar Gordon Hockey, said: "It was always going to be tough to beat last year's record turnout, even with a record number of candidates standing this year, but it's encouraging that voter numbers are still the third highest in the last ten years.
"I'd like to be amongst the first to publicly congratulate all the successful candidates this year, and to encourage those who weren't successful this time to stand again in the future. I'm very much looking forward to working with our three new RCVS Council members whilst, at the same time, delighted that the profession has returned three existing members to their seats, enabling them to continue their work for the College."
Chair of VN Council, Kathy Kissick, says: "Many congratulations to Hilary, who has been returned to the VN Council for the third time running, and to Amber, who I'm looking forward to welcoming to VN Council in July. Hilary's experience and Amber's fresh input will, I'm sure, combine to provide an excellent contribution to our ongoing work."
Eli Lilly and Company, which owns Elanco Animal Health, has announced an agreement to acquire Novartis Animal Health for approximately $5.4 billion in cash.
Lilly says that on completion of the deal, Elanco will be the second-largest animal health company in terms of global revenue. It will also solidify its number two ranking in the U.S., and improve its position in Europe and the rest of the world.
As part of the agreement, Lilly will acquire Novartis Animal Health's nine manufacturing sites, six dedicated research and development facilities, a global commercial infrastructure with a portfolio of approximately 600 products, a pipeline with more than 40 projects in development, and an experienced team of more than 3,000 employees.
The transaction is expected to be completed by the end of the first quarter of 2015, subject to clearance under the U.S. Hart-Scott-Rodino Antitrust Improvements Act, similar requirements outside the U.S., and other customary closing conditions.
John C. Lechleiter, Ph.D., Lilly's chairman, president and chief executive officer said: "Animal health continues to represent an attractive growth opportunity for Lilly. We intend to keep Elanco and to take advantage of the substantial synergies between our animal health and human health businesses.
"Significant investments in our animal health business in recent years have enabled Elanco to double its revenue since 2008, leading the industry in growth. Global trends suggest continued sustained demand for animal health products in the years ahead. Through this acquisition, which moves Elanco to top-tier in the industry, we intend to create value for our shareholders by adding to our promising pipeline of innovative animal health assets, increasing sales through a larger commercial footprint, and improving efficiencies and lowering costs."
The British Association of Veterinary Emergency & Critical Care has released the results of a survey into practitioners attitudes to 24-7 and OOH home visits.
360 veterinary surgeons took part in the survey, nearly all of whom have been practising for more than 2 years. 70% work in small animal practice, 12% at a dedicated OOH provider, and the bulk of the remainder in referral or mixed practice. 81% described the work they do as small animal first opinion, and 76% were employees. 35% said they had already responded to the RCVS call for evidence on the provision of 24/7 emergency cover.
26% said they work for a practice that outsources its OOH to a dedicated provider, and more than 85% of those said they would not return to an on-call system.
In terms of dedicated out-of-hours providers, a clear pattern emerged. Namely those practitioners who outsource their OOH feel that patient care, staff safety and professional well-being are all enhanced by dedicated OOH services, but that dedicated OOH comes at a cost of reduced value for money for the pet owner. Customer service between the different OOH provisions is perceived to be similar (on-call better 25%, same 48%, and dedicated better 27%).
Among those practitioners who work for a dedicated OOH service, dedicated OOH services perform best in all categories. 68% responded that OOH customer service is better with a dedicated OOH service compared to an on-call system (12% responded that on-call provided better customer service on average). 44% responded that customer value for money was better with dedicated OOH service compared to 19% who responded that customer value for money was on average better with an on-call system.
Among those practitioners who do their own on-call, customer service and value for money were perceived to be better with an on-call system (42% v 26% and 61% v 15% respectively). In the other categories dedicated OOH services again out-performed an on-call system.
Whether routine or emergency, 'owner demands' were felt to be the biggest reason for home visit requests (41% and 30% respectively). However, 'genuine clinical need' was the main reason cited by 19% of respondents as the main reason for emergency home visits. Inability to move the animal was given as the main reason by a further 28%.
Participants in the survey were asked to score (out of 10) how much their decision to perform a home visit was affected by the threat of a complaint, either to their employer or to the RCVS. Interestingly, 37% said a complaint to their employer weighed heavily on the decision (ranking it 8 or higher) where, by comparison, 52% said the threat of a complaint to the College ranked 8 or higher in their decision making.
69% of respondents said they make visits alone, either sometimes or always. When asked if they had ever felt threatened whilst performing an OOH visit, 48% said yes. This compared to 23% who said that they had felt threatened when performing a visit in normal hours.
When asked to rank (out of 10) the stress home visits cause, 7% said none at all and 36% said 8 or above.
72% said they believe that the profession should continue to be obligated to provide 24/7 for animals.
Respondents were then asked to say whether they support or disagree with the suggestion that the need to perform house visits is removed from the CoPC. 59% were strongly for the idea (scoring it up to 3), compared to 22% who were strongly against it (scoring it 8 or above).
Opinions about whether the College should clarify the need to perform house visits was far more clear cut. 77% strongly supported clarification (scored up to 3), whereas only 16% said there was no need (scored 8 or above).
However, an overwhelming 93% said that they would continue to perform visits in the case of genuine clinical need even if the Code of Professional Conduct was changed to make it dear that there was no risk of disciplinary action for not attending off-site.